Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Influence of Food Intake on the Healing Process of Postoperative Pancreatic Fistula After Pancreatoduodenectomy: A Multi-institutional Randomized Controlled Trial.
Fujii T, Nakao A, Murotani K, Okamura Y, Ishigure K, Hatsuno T, Sakai M, Yamada S, Kanda M, Sugimoto H, Nomoto S, Takeda S, Morita S, Kodera Y. Fujii T, et al. Among authors: ishigure k. Ann Surg Oncol. 2015 Nov;22(12):3905-12. doi: 10.1245/s10434-015-4496-1. Epub 2015 Mar 17. Ann Surg Oncol. 2015. PMID: 25777090 Clinical Trial.
Early results of multicenter phase II trial of perioperative oxaliplatin and capecitabine without radiotherapy for high-risk rectal cancer: CORONA I study.
Kamiya T, Uehara K, Nakayama G, Ishigure K, Kobayashi S, Hiramatsu K, Nakayama H, Yamashita K, Sakamoto E, Tojima Y, Kawai S, Kodera Y, Nagino M; Nagoya Surgical Oncology Group and the Chubu Clinical Oncology Group. Kamiya T, et al. Among authors: ishigure k. Eur J Surg Oncol. 2016 Jun;42(6):829-35. doi: 10.1016/j.ejso.2016.02.014. Epub 2016 Feb 27. Eur J Surg Oncol. 2016. PMID: 26968228 Clinical Trial.
Phase II multi-institutional prospective trial of nab-paclitaxel as second-line chemotherapy for advanced gastric cancer refractory to fluoropyrimidine with modified dose reduction criteria (CCOG1303).
Kobayashi D, Mochizuki Y, Torii K, Takeda S, Kawase Y, Ishigure K, Teramoto H, Ando M, Kodera Y. Kobayashi D, et al. Among authors: ishigure k. Int J Clin Oncol. 2020 Oct;25(10):1793-1799. doi: 10.1007/s10147-020-01724-8. Epub 2020 Jun 21. Int J Clin Oncol. 2020. PMID: 32567012 Clinical Trial.
Protocol of a phase II study investigating the efficacy and safety of trifluridine/tipiracil plus ramucirumab as a third-line or later treatment for advanced gastric cancer.
Nakanishi K, Tanaka C, Kanda M, Miyata K, Machida N, Sakai M, Kobayashi D, Teramoto H, Ishiyama A, Sato B, Oshima T, Kajikawa M, Matsushita H, Ishigure K, Yamashita K, Fujitake S, Sueoka S, Asada T, Shimizu D, Sugita S, Kuwatsuka Y, Maeda O, Furune S, Murotani K, Ando Y, Ebata T, Kodera Y. Nakanishi K, et al. Among authors: ishigure k. Nagoya J Med Sci. 2024 Feb;86(1):43-51. doi: 10.18999/nagjms.86.1.43. Nagoya J Med Sci. 2024. PMID: 38505718 Free PMC article.
The alpha-ketoisocaproate catabolism in human and rat livers.
Xu M, Nakai N, Ishigure K, Nonami T, Nagasaki M, Obayashi M, Li Z, Sato Y, Fujitsuka N, Murakami T, Shimomura Y. Xu M, et al. Among authors: ishigure k. Biochem Biophys Res Commun. 2000 Oct 5;276(3):1080-4. doi: 10.1006/bbrc.2000.3566. Biochem Biophys Res Commun. 2000. PMID: 11027593
78 results